The HDAC inhibitor panobinostat (LBH589) exerts in vivo anti-leukaemic activity against MLL-rearranged acute lymphoblastic leukaemia and involves the RNF20/RNF40/WAC-H2B ubiquitination axis
P. Garrido Castro, E. H.J. Van Roon, S. S. Pinhanços, L. Trentin, P. Schneider, M. Kerstjens, G. Te Kronnie, O. Heidenreich, R. Pieters, R. W. Stam
Research output: Contribution to journal › Article › peer-review
48Citations
(Scopus)
Fingerprint
Dive into the research topics of 'The HDAC inhibitor panobinostat (LBH589) exerts in vivo anti-leukaemic activity against MLL-rearranged acute lymphoblastic leukaemia and involves the RNF20/RNF40/WAC-H2B ubiquitination axis'. Together they form a unique fingerprint.